MIR132

Across TCGA pan-cancer cohorts, MIR132 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated MIR132 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR132 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR132 expression acts as an unfavorable survival marker, although some lineages such as BLCA and STAD show a favorable association.

LUAD, KIRP, and BLCA are the cancer types where MIR132 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	0.223	0.749	.013	54	view →
KIRP	DFS	Tertile	All	0.174	0.617	.001	18	view →
BLCA	DFS	Tertile	All	0.816	0.498	.033	15	view →
KIRC	OS	Tertile	All	0.438	0.665	.021	12	view →
STAD	OS	Median	III,IV	0.681	0.326	.007	12	view →
ESCA	OS	Tertile	IV	0.243	0.590	.046	12	view →
THCA	DFS	Tertile	IV	0.243	0.801	.021	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

MIR132–LUAD (OS)

Open the LUAD breakdown →